General
Release from Glaxo Smith Kline (BIOC.CA) Concerning the Stock Price
Published at 20 July 2026 at 13:10Glaxo Smith KlineRelated stock:Glaxo Smith Kline stockAll Glaxo Smith Kline disclosures
Disclosure summary
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Release from the company stating that there is no material information that justify the stock movement.
Release from the Company (201 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Release from the company stating that there is no material information that justify the stock movement.
Release from the Company (201 KB)